# Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US

> **NCT06051669** · — · UNKNOWN · sponsor: **New Discovery LLC** · enrollment: 418 (estimated)

## Conditions studied

- Liver Fibrosis
- Fatty Liver

## Interventions

- **DEVICE:** iLivTouch
- **DEVICE:** FibroScan

## Key facts

- **NCT ID:** NCT06051669
- **Lead sponsor:** New Discovery LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-24
- **Primary completion:** 2024-09
- **Final completion:** 2025-03
- **Target enrollment:** 418 (ESTIMATED)
- **Last updated:** 2023-10-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06051669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06051669, "Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06051669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*